Humana Inc. $HUM Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB lowered its stake in shares of Humana Inc. (NYSE:HUM) by 73.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,321 shares of the insurance provider’s stock after selling 9,256 shares during the period. Handelsbanken Fonder AB’s holdings in Humana were worth $1,319,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Humana by 4.1% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock valued at $66,207,000 after purchasing an additional 9,960 shares in the last quarter. Sustainable Insight Capital Management LLC boosted its position in Humana by 23.7% during the fourth quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock worth $6,341,000 after purchasing an additional 4,740 shares in the last quarter. Swedbank AB grew its holdings in Humana by 6.2% in the fourth quarter. Swedbank AB now owns 111,803 shares of the insurance provider’s stock valued at $28,636,000 after purchasing an additional 6,534 shares during the last quarter. North Dakota State Investment Board acquired a new stake in Humana in the fourth quarter valued at $1,517,000. Finally, Pzena Investment Management LLC increased its position in shares of Humana by 1.0% in the fourth quarter. Pzena Investment Management LLC now owns 4,072,208 shares of the insurance provider’s stock valued at $1,043,015,000 after buying an additional 41,125 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

HUM has been the subject of several research reports. TD Cowen lifted their price target on Humana from $350.00 to $370.00 and gave the stock a “hold” rating in a research note on Friday, July 31st. The Goldman Sachs Group raised their target price on shares of Humana from $158.00 to $195.00 and gave the company a “sell” rating in a report on Thursday, April 30th. Raymond James Financial downgraded shares of Humana from an “outperform” rating to a “market perform” rating in a report on Thursday, July 30th. Guggenheim increased their price target on shares of Humana from $269.00 to $471.00 and gave the company a “buy” rating in a research report on Thursday, July 30th. Finally, Cantor Fitzgerald raised their price objective on shares of Humana from $264.00 to $300.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 7th. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $395.22.

Humana Trading Down 0.6%

Humana stock opened at $382.13 on Wednesday. The stock has a 50-day moving average price of $382.93 and a 200 day moving average price of $278.32. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $428.88. The stock has a market cap of $45.89 billion, a PE ratio of 36.15, a P/E/G ratio of 2.23 and a beta of 0.72. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62.

Humana (NYSE:HUM) last released its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. During the same period in the prior year, the firm earned $6.27 EPS. The firm’s quarterly revenue was up 26.2% on a year-over-year basis. Equities research analysts predict that Humana Inc. will post 9.08 earnings per share for the current fiscal year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.